Bioorganic and Medicinal Chemistry Letters p. 731 - 736 (2014)
Update date:2022-09-26
Topics:
Namoto, Kenji
Sirockin, Finton
Ostermann, Nils
Gessier, Francois
Flohr, Stefanie
Sedrani, Richard
Gerhartz, Bernd
Trappe, J?rg
Hassiepen, Ulrich
Duttaroy, Alokesh
Ferreira, Suzie
Sutton, Jon M.
Clark, David E.
Fenton, Garry
Beswick, Mandy
Baeschlin, Daniel K.
The successful launches of dipeptidyl peptidase IV (DPP IV) inhibitors as oral anti-diabetics warrant and spur the further quest for additional chemical entities in this promising class of therapeutics. Numerous pharmaceutical companies have pursued their proprietary candidates towards the clinic, resulting in a large body of published chemical structures associated with DPP IV. Herein, we report the discovery of a novel chemotype for DPP IV inhibition based on the C-(1-aryl-cyclohexyl)-methylamine scaffold and its optimization to compounds which selectively inhibit DPP IV at low-nM potency and exhibit an excellent oral pharmacokinetic profile in the rat. 2014 Elsevier Ltd. All rights reserved.
View MoreFrapp's Chemical (NFTZ) Co.,Ltd
Contact:+86-576-86137892
Address:General Chamber of Commercial Building, 159 Wanchang Middle Road, Wenling, Zhejiang, China
Anhui Sholon New Material Technology Co., Ltd.
website:http://www.sholonchem.com
Contact:+86-550-5261666
Address:4/F Block B, Beijing Chemical Building.No.520 Tianrun Road ,Science & Education Town Wujin District, Changzhou City Jiangsu Province
Synochem Ingredients Corp., Ltd.
Contact:+86-512-5636 2180
Address:Zhangjiagang Free Trade Zone
Frapp's Chemical (NFTZ) Co.,Ltd
Contact:+86-576-86137892
Address:General Chamber of Commercial Building, 159 Wanchang Middle Road, Wenling, Zhejiang, China
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Doi:10.1021/ol0267681
(2003)Doi:10.1007/BF00515243
(1985)Doi:10.1016/S0040-4020(01)87535-9
(1986)Doi:10.1002/1521-3765(20021104)8:21<4946::AID-CHEM4946>3.0.CO;2-V
(2002)Doi:10.1080/15257770500230467
(2005)Doi:10.1021/ac020377i
(2003)